Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M
Eberhard-Karls-Universität, Tübingen, Germany.
Eur J Clin Invest. 2000 May;30(5):411-8. doi: 10.1046/j.1365-2362.2000.00649.x.
Characterization of beta-cell function in humans is essential for identifying genetic defects involved in abnormal insulin secretion and the pathogenesis of type 2 diabetes.
We designed a novel test assessing plasma insulin and C-peptide in response to 3 different secretagogues. Seven lean, healthy volunteers twice underwent a 200 min hyperglycaemic clamp (10 mmol L-1) with administration of GLP-1 (1.5 pmol. kg-1. min-1) starting at 120 min and an arginine bolus at 180 min. We determined glucose-induced first and second-phase insulin secretion, GLP-1-stimulated insulin secretion, arginine-stimulated insulin response (increase above prestimulus, DeltaIarg) and the maximal, i. e. highest absolute, insulin concentration (Imax). Insulin sensitivity was assessed during second-phase hyperglycaemia. On a third occasion 6 subjects additionally received an arginine bolus at > 25 mM blood glucose, a test hitherto claimed to provoke maximal insulin secretion.
Insulin levels increased from 46 +/- 11 pM to 566 +/- 202 pM at 120 min, to 5104 +/- 1179 pM at 180 min and to maximally 8361 +/- 1368 pM after arginine (all P < 0.001). The within subject coefficients of variation of the different secretion parameters ranged from 10 +/- 3% to 16 +/- 6%. Except for second-phase which failed to correlate significantly with DeltaIarg (r = 0.52, P = 0.23) and Imax (r = 0.75, P = 0.053) all phases of insulin secretion correlated with one another. The insulin concentration after the arginine bolus at > 25 mM glucose (n = 6) was 2773 +/- 855 pM vs. 7562 +/- 1168 pM for Imax (P = 0.003).
This novel insulin secretion test elicits a distinct pattern of plasma insulin concentrations in response to the secretagogues glucose, GLP-1 and arginine and is highly reproducible and can be used for differential characterization of islet function.
了解人类β细胞功能对于识别胰岛素分泌异常及2型糖尿病发病机制中涉及的遗传缺陷至关重要。
我们设计了一项新型试验,评估血浆胰岛素和C肽对3种不同促分泌素的反应。7名体型偏瘦的健康志愿者两次接受了200分钟的高血糖钳夹试验(10 mmol/L),在120分钟时开始输注胰高血糖素样肽-1(GLP-1,1.5 pmol·kg-1·min-1),并在180分钟时给予精氨酸推注。我们测定了葡萄糖诱导的第一相和第二相胰岛素分泌、GLP-1刺激的胰岛素分泌、精氨酸刺激的胰岛素反应(刺激后增加量,ΔIarg)以及最大即最高绝对胰岛素浓度(Imax)。在第二相高血糖期间评估胰岛素敏感性。在第三次试验中,6名受试者在血糖>25 mM时额外接受了精氨酸推注,这是一种迄今声称能引发最大胰岛素分泌的试验。
胰岛素水平在120分钟时从46±11 pM增加到566±202 pM,在180分钟时增加到5104±1179 pM,精氨酸注射后最大增加到8361±1368 pM(所有P<0.001)。不同分泌参数的受试者内变异系数范围为10±3%至